The Systemic Redox Status Is Maintained in Non-Smoking Type 2 Diabetic Subjects Without Cardiovascular Disease: Association with Elevated Triglycerides and Large VLDL

• Main Authors: Peter R. van Dijk, Amaal Eman Abdulle, Marian L.C. Bulthuis, Frank G. Perton, Margery A. Connelly, Harry van Goor, Robin P.F. Dullaart
• Format: Article
• Language: English
• Published: MDPI AG 2019-12-01
• Series: Journal of Clinical Medicine
• Subjects: adiponectin; free thiols; nuclear magnetic resonance spectroscopy; phospholipid transfer protein activity; triglycerides; type 2 diabetes mellitus; large very low density lipoproteins
• Online Access: https://www.mdpi.com/2077-0383/9/1/49

Decreased circulating levels of free thiols (R-SH, sulfhydryl groups) reflect enhanced oxidative stress, which plays an important role in the pathogenesis of cardiometabolic diseases. Since hyperglycemia causes oxidative stress, we questioned whether plasma free thiols are altered in patients with type 2 diabetes mellitus (T2DM) without cardiovascular disease or renal function impairment. We also determined their relationship with elevated triglycerides and very low density lipoproteins (VLDL), a central feature of diabetic dyslipidemia. Fasting plasma free thiols (colorimetric method), lipoproteins, VLDL (nuclear magnetic resonance spectrometry), free fatty acids (FFA), phospholipid transfer protein (PLTP) activity and adiponectin were measured in 79 adult non-smoking T2DM subjects (HbA1c 51 &#177; 8 mmol/mol, no use of insulin or lipid lowering drugs), and in 89 non-smoking subjects without T2DM. Plasma free thiols were univariately correlated with glucose (r = 0.196, <i>p</i> &lt; 0.05), but were not decreased in T2DM subjects versus non-diabetic subjects (<i>p</i> = 0.31). Free thiols were higher in subjects with (663 &#177; 84 &#181;mol/L) versus subjects without elevated triglycerides (619 &#177; 91 &#181;mol/L; <i>p</i> = 0.002). Age- and sex-adjusted multivariable linear regression analysis demonstrated that plasma triglycerides were positively and independently associated with free thiols (&#946; = 0.215, <i>p</i> = 0.004), FFA (&#946; = 0.168, <i>p</i> = 0.029) and PLTP activity (&#946; = 0.228, <i>p</i> = 0.002), inversely with adiponectin (&#946; = &#8722;0.308, <i>p</i> &lt; 0.001) but not with glucose (&#946; = 0.052, <i>p</i> = 0.51). Notably, the positive association of free thiols with (elevated) triglycerides appeared to be particularly evident in men. Additionally, large VLDL were independently associated with free thiols (&#946; = 0.188, <i>p</i> = 0.029). In conclusion, circulating free thiols are not decreased in this cohort of non-smoking and generally well-controlled T2DM subjects. Paradoxically, higher triglycerides and more large VLDL particles are likely associated with higher plasma levels of thiols, reflecting lower systemic oxidative stress.